News Releases

Feb 09, 2022 Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading
Displaying 11 - 11 of 11
Print Page
Email Alerts
Contact IR
RSS Feeds